Culpepper-Morgan J A, Kreek M J
The Biology of Addictive Diseases Laboratory, The Rockefeller University, New York, NY 10021, USA.
Metabolism. 1997 Feb;46(2):130-4. doi: 10.1016/s0026-0495(97)90289-4.
A case of opioid withdrawal precipitated in an opioid-dependent person by low plasma levels of naloxone is presented. In this patient, changes were observed in the hypothalamic-pituitary-adrenal (HPA) axis that preceded the clinical symptoms and adrenergic signs of withdrawal. Plasma naloxone levels were strongly correlated with plasma cortisol levels (P < .0001, R2 = .73, r = .85). In addition, these neuroendocrine changes persisted after adrenergic changes and clinical symptoms had been ameliorated by administration of a short-acting opioid agonist. It is suggested that the HPA axis is a more sensitive indicator of opioid withdrawal than the adrenergic system.
本文报告了一例因血浆中纳洛酮水平过低而导致阿片类药物依赖者出现阿片类药物戒断反应的病例。在该患者中,下丘脑 - 垂体 - 肾上腺(HPA)轴的变化先于戒断的临床症状和肾上腺素能体征出现。血浆纳洛酮水平与血浆皮质醇水平密切相关(P <.0001,R2 =.73,r =.85)。此外,在给予短效阿片类激动剂使肾上腺素能变化和临床症状得到改善后,这些神经内分泌变化仍持续存在。研究表明,HPA轴比肾上腺素能系统更能敏感地指示阿片类药物戒断反应。